MDCalc is the clinical calculator platform most doctors reach for instinctively. It is well-designed, fast, and covers an enormous range of scores and formulas. If you trained in the US or used MDCalc during medical school, it is probably bookmarked on your phone.
But MDCalc was built for the US healthcare system. Its default clinical context is American — ACC/AHA guidelines, USPSTF screening thresholds, FDA-approved drug dosing, and US-specific referral pathways. For UK doctors practising under NICE, BNF, SIGN, and RCGP guidance, this creates a subtle but clinically significant problem: the calculation is correct, but the interpretation and next-step guidance reference the wrong guidelines.
This is not a theoretical concern. It leads to real clinical errors — and iatroX Calculators was built specifically to solve it.
Where MDCalc's US Context Creates Problems for UK Doctors
Cardiovascular risk assessment. MDCalc's default CVD risk tool is the ACC/AHA Pooled Cohort Equations (ASCVD PCE) — the standard in US practice. In the UK, cardiovascular risk assessment uses QRISK3, which includes different variables (deprivation index, ethnicity categories specific to UK populations, systemic lupus, atypical antipsychotics, migraine, severe mental illness), uses a different threshold for treatment initiation (NICE CG181: 10% ten-year risk vs ACC/AHA: 7.5%), and recommends a different first-line statin (atorvastatin 20mg per NICE vs high-intensity statin per ACC/AHA). A UK GP using the ASCVD calculator instead of QRISK3 might under-treat a patient who qualifies for statins under NICE, or over-treat one who does not.
Pneumonia severity. MDCalc provides both CURB-65 and the Pneumonia Severity Index (PSI/PORT). The interpretation for CURB-65 references the American Thoracic Society and Infectious Disease Society of America (ATS/IDSA) guidelines. In UK practice, the CURB-65 interpretation follows the BTS/NICE community-acquired pneumonia pathway — which specifies different management actions per severity band, different antibiotic choices, and different admission thresholds. A score of 2 in UK practice means "consider hospital admission and oral amoxicillin" per BTS. On MDCalc, the management guidance does not reference BTS or NICE.
Atrial fibrillation anticoagulation. MDCalc's CHA₂DS₂-VASc interpretation references ACC/AHA/HRS guidelines. In UK practice, anticoagulation thresholds and drug selection follow NICE NG196 — which specifies DOACs as first-line over warfarin for most patients, identifies specific exceptions (mechanical valves, moderate-to-severe mitral stenosis), and defines the shared decision-making framework differently from US guidelines.
Renal function. MDCalc defaults to creatinine in mg/dL (US convention). UK laboratories report creatinine in µmol/L. While MDCalc does offer unit conversion, the default creates friction — and in a fast-paced clinical environment, using the wrong unit in a Cockcroft-Gault or CKD-EPI calculation produces a dangerously incorrect result.
What a UK-Contextualised Calculator Platform Looks Like
iatroX Calculators provides 80+ clinical calculators where every result is interpreted against the UK guideline — NICE, BNF, SIGN, BTS, RCOG, or the relevant UK professional body standard.
A QRISK3 result of 12% on iatroX tells you this exceeds the NICE CG181 10% threshold for offering atorvastatin 20mg, references the shared decision-making conversation framework, and notes the relevant lifestyle modification recommendations — all specific to NICE, not ACC/AHA.
A CURB-65 score of 2 on iatroX references the BTS/NICE pathway: hospital admission should be considered, oral amoxicillin is first-line, consider dual therapy if moderate-to-severe.
A CHA₂DS₂-VASc score of 2 in a male on iatroX references NICE NG196: anticoagulation recommended, DOAC first-line, with specific guidance on when warfarin is preferred.
Every calculator defaults to UK units (µmol/L for creatinine, mmol/L for glucose, mmol/mol for HbA1c). Clinical pearls on every tool highlight the UK-specific practical considerations. Cross-linked related calculators connect one score to the next in the UK clinical pathway.
Semantic search means you type "CVD risk" and get QRISK3 — not the ASCVD Pooled Cohort Equations as the top result. The search understands UK clinical thinking.
MDCalc vs iatroX — A Fair Comparison
MDCalc remains a strong tool — its calculation engine is reliable, its coverage is vast (600+ calculators), and its interface is clean. For US clinicians, it is excellent. For UK clinicians, it is useful but contextually misaligned.
| Feature | MDCalc | iatroX Calculators |
|---|---|---|
| Calculator count | 600+ | 80+ |
| Default clinical context | US (ACC/AHA, ATS/IDSA) | UK (NICE, BNF, BTS, SIGN) |
| Default units | US (mg/dL, lb) | UK (µmol/L, kg) |
| NICE-referenced interpretation | No | Yes |
| BNF-aligned drug guidance | No | Yes |
| Cross-linked UK clinical pathways | No | Yes |
| Clinical pearls (UK-specific) | Some | Yes — every calculator |
| Ads | Yes | No |
| Semantic search | Yes | Yes |
| Mobile optimised | Yes | Yes |
The recommendation is not to abandon MDCalc entirely — it has calculators that iatroX does not yet cover, and its sheer breadth is useful for rare or specialist scores. The recommendation is to use iatroX Calculators as your primary calculator platform for the scores you use daily in UK practice — CVD risk, pneumonia severity, AF anticoagulation, renal function, liver fibrosis, PE workup, sepsis screening, mental health assessment — where the UK guideline context directly affects the clinical decision.
For everything else, MDCalc remains a useful secondary reference.
When the Wrong Calculator Changes the Decision
The difference between QRISK3 and ASCVD is not academic. A 55-year-old South Asian male with treated hypertension and a family history of premature CVD might score 8.2% on ASCVD (below the US 7.5% soft threshold — "consider discussion") but 13.4% on QRISK3 (above the NICE 10% threshold — offer atorvastatin). Using the wrong tool in the wrong country leads to the wrong treatment decision.
For medical exams, this distinction is directly tested. The MRCGP AKT expects you to use QRISK3 and apply NICE CG181 thresholds — not ASCVD and ACC/AHA thresholds. The UKMLA tests UK-specific management. Using US-aligned calculator interpretation during revision embeds the wrong thresholds in your memory.
iatroX Calculators ensures every calculation you do — whether in clinical practice or during revision — gives you the UK-guideline-aligned answer. Available free at iatrox.com/calculators.